![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1470, 2005-01, pp. : 20-20
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Novartis Pharma has received expanded approval in Japan for pamidronic acid
Inpharma, Vol. 1, Iss. 1471, 2005-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Tiotropium bromide [Spiriva; Boehringer Ingelheim] has received final approval in Japan
Inpharma, Vol. 1, Iss. 1465, 2004-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Rosuvastatin [Crestor; AstraZeneca] has received a positive opinion in Japan
Inpharma, Vol. 1, Iss. 1467, 2004-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Sevelamer [`Renagel'; Genzyme General] has received marketing approval in Brazil.
Inpharma, Vol. 1, Iss. 1302, 2001-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Thymalfasin [`Zadaxin'; SciClone] has received marketing approval in Mexico
Inpharma, Vol. 1, Iss. 1298, 2001-01 ,pp. :